Bilateral Optic Neuropathy Following Methanol Ingestion: A Review of Published Cases
DOI:
https://doi.org/10.5281/zenodo.22279133Keywords:
Methanol poisoning, Optic neuropathy, Formate, Metabolic acidosis, Alcohol dehydrogenase inhibitorsAbstract
ackground: Methanol poisoning causes acidosis and bilateral visual failure through its metabolite formate rather than through
methanol itself, often after a latent interval when the patient appears well. Objective: To set out which published variables predict blindness and death, and which treatments the record supports. Methods: Narrative review of published outbreak cohorts, prospective and retrospective series and case reports. Findings: In 38 prospectively studied patients, serum formate discriminated outcome with an area under the curve of 0.64 against 0.54 for serum methanol. In an ophthalmic series of 21 patients, mean blood methanol was higher in those without ocular symptoms. Admission arterial pH below 7.3 carried a risk estimate of 11.65 for chronic retinal nerve fibre layer loss in 42 survivors. Conclusions: The published record supports decisions based on pH, base deficit and formate and early blockade of alcohol dehydrogenase; it does not support reassurance from a blood methanol concentration.
References
Barceloux, D.G., Bond, G.R., Krenzelok, E.P., Cooper, H., Vale, J.A. (2002) American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Journal of Toxicology: Clinical Toxicology, 40(4): 415-446.
Liberski, S., Kaluzny, B.J., Kociecki, J. (2022) Methanol-induced optic neuropathy: a still-present problem. Archives of Toxicology, 96(2): 431-451.
McMartin, K.E., Ambre, J.J., Tephly, T.R. (1980) Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. American Journal of Medicine, 68(3): 414-418.
Zakharov, S., Kurcova, I., Navratil, T., Salek, T., Komarc, M., Pelclova, D. (2015) Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic and Clinical Pharmacology and Toxicology, 116(5): 445-451.
Rym, M., Wijden, N., Hela, M., Hela, S., Nozha, B., Cheour, M. (2023) Ocular manifestations after acute methanol poisoning. Neuro-Ophthalmology, 47(4): 193-198.
Hovda, K.E., Hunderi, O.H., Tafjord, A.B., Dunlop, O., Rudberg, N., Jacobsen, D. (2005) Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs. Journal of Internal Medicine, 258(2): 181-190.
Desai, T., Sudhalkar, A., Vyas, U., Khamar, B. (2013) Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmology, 131(3): 358-364.
Zakharov, S., Pelclova, D., Urban, P., Navratil, T., Diblik, P., Kuthan, P., et al. (2014) Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features. Clinical Toxicology, 52(10): 1013-1024.
Paasma, R., Hovda, K.E., Hassanian-Moghaddam, H., Brahmi, N., Afshari, R., Sandvik, L., et al. (2012) Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes - a multicenter study. Clinical Toxicology, 50(9): 823-831.
Nurieva, O., Diblik, P., Kuthan, P., Sklenka, P., Meliska, M., Bydzovsky, J., et al. (2018) Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. American Journal of Ophthalmology, 191: 100-115.
Sun, Q., Sun, M., Zhang, Y., Wang, S., Bai, W., Wei, S., et al. (2022) Clinical characteristics of methanol-induced optic neuropathy: correlation between aetiology and clinical findings. Journal of Ophthalmology, 2022: 4671671.
Yang, C.S., Tsai, W.J., Lirng, J.F. (2005) Ocular manifestations and MRI findings in a case of methanol poisoning. Eye, 19(7): 806-809.
Galvez-Ruiz, A., Elkhamary, S.M., Asghar, N., Bosley, T.M. (2015) Cupping of the optic disk after methanol poisoning. British Journal of Ophthalmology, 99(9): 1220-1223.
Paasma, R., Hovda, K.E., Tikkerberi, A., Jacobsen, D. (2007) Methanol mass poisoning in Estonia: outbreak in 154 patients. Clinical Toxicology, 45(2): 152-157.
Paasma, R., Hovda, K.E., Jacobsen, D. (2009) Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak. BMC Clinical Pharmacology, 9: 5.
Zakharov, S., Pelclova, D., Diblik, P., Urban, P., Kuthan, P., Nurieva, O., et al. (2015) Long-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clinical Toxicology, 53(9): 884-892.
Sanaei-Zadeh, H., Zamani, N., Shadnia, S. (2011) Outcomes of visual disturbances after methanol poisoning. Clinical Toxicology, 49(2): 102-107.
Zakharov, S., Pelclova, D., Urban, P., Navratil, T., Nurieva, O., Kotikova, K., et al. (2016) Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Annals of Emergency Medicine, 68(1): 52-61.
Brent, J., McMartin, K., Phillips, S., Aaron, C., Kulig, K. (2001) Fomepizole for the treatment of methanol poisoning. New England Journal of Medicine, 344(6): 424-429.
McMartin, K., Jacobsen, D., Hovda, K.E. (2016) Antidotes for poisoning by alcohols that form toxic metabolites. British Journal of Clinical Pharmacology, 81(3): 505-515.
Roberts, D.M., Yates, C., Megarbane, B., Winchester, J.F., Maclaren, R., Gosselin, S., et al. (2015) Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Critical Care Medicine, 43(2): 461-472.
Hassanian-Moghaddam, H., Zamani, N., Roberts, D.M., Brent, J., McMartin, K., Aaron, C., et al. (2019) Consensus statements on the approach to patients in a methanol poisoning outbreak. Clinical Toxicology, 57(12): 1129-1136.
Pakdel, F., Sanjari, M.S., Naderi, A., Pirmarzdashti, N., Haghighi, A., Kashkouli, M.B. (2018) Erythropoietin in treatment of methanol optic neuropathy. Journal of Neuro-Ophthalmology, 38(2): 167-171.
Tabatabaei, S.A., Amini, M., Haydar, A.A., Soleimani, M., Cheraqpour, K., Shahriari, M., et al. (2023) Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World Journal of Clinical Cases, 11(15): 3502-3510.
Pakravan, M., Sanjari, N. (2012) Erythropoietin treatment for methanol optic neuropathy. Journal of Neuro-Ophthalmology, 32(4): 325-328.
Pakravan, M., Esfandiari, H., Sanjari, N., Ghahari, E. (2016) Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. American Journal of Drug and Alcohol Abuse, 42(6): 633-639.
Alrobaian, M., Alkhuraiji, A., Almohanna, R., Alshehri, M., Alyahya, B. (2024) Visual outcome of methanol toxic optic neuropathy after erythropoietin treatment in Riyadh, Saudi Arabia. Saudi Journal of Ophthalmology, 38(1): 41-46.
Sharma, R., Marasini, S., Sharma, A.K., Shrestha, J.K., Nepal, B.P. (2012) Methanol poisoning: ocular and neurological manifestations. Optometry and Vision Science, 89(2): 178-182.
